View ValuationHuafon ChemicalLtd 将来の成長Future 基準チェック /26Huafon ChemicalLtd利益と収益がそれぞれ年間25%と6.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に11.8% 25.1%なると予測されています。主要情報25.0%収益成長率25.09%EPS成長率Chemicals 収益成長30.6%収益成長率6.5%将来の株主資本利益率11.80%アナリストカバレッジLow最終更新日19 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 16Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang Chinaお知らせ • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 22, 2026Huafon Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 22, 2026お知らせ • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Mar 28, 2026Huafon Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Mar 28, 2026お知らせ • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 25, 2025Huafon Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 25, 2025お知らせ • Sep 04Huafon Chemical Co.,Ltd Proposes Interim Cash Dividend for the Year 2025Huafon Chemical Co.,Ltd proposed interim cash dividend of CNY 0.50000000 per 10 shares for the year 2025.お知らせ • Jul 02Huafon Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 12, 2025Huafon Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 12, 2025お知らせ • Apr 01Huafon Chemical Co.,Ltd Proposes Final Cash Dividend for the Year 2024Huafon Chemical Co.,Ltd announced that on 31 March 2025 the profit distribution proposal for 2024: Cash dividend (tax included) of CNY 1.50000000 per 10 shares.お知らせ • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 26, 2025Huafon Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 26, 2025お知らせ • Mar 29Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang Chinaお知らせ • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Mar 29, 2025Huafon Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Mar 29, 2025お知らせ • Oct 31Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd.Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd. on October 28, 2024. The consideration consist of cash and common equity.お知らせ • Oct 30Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua.Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua on October 28, 2024. Huafon Chemical intends to acquire 100% of the equity of Zhejiang Huafon Synthetic Resin through issuing shares and paying cash. After the agreement is signed, both parties will continue to actively communicate, verify, and negotiate specific details of the transaction plan, transaction method, transaction price, share issuance price, share issuance quantity, and other matters, and will subsequently sign all formal agreements related to this transaction.Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.12 in 3Q 2023). Revenue: CN¥6.63b (down 6.1% from 3Q 2023). Net income: CN¥496.5m (down 13% from 3Q 2023). Profit margin: 7.5% (down from 8.1% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 26, 2024Huafon Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥7.78, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.79 per share.Reported Earnings • Aug 10Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥7.09b (up 10% from 2Q 2023). Net income: CN¥834.7m (up 15% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.お知らせ • Jun 29Huafon Chemical Co.,Ltd to Report First Half, 2024 Results on Aug 10, 2024Huafon Chemical Co.,Ltd announced that they will report first half, 2024 results on Aug 10, 2024お知らせ • May 28Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024, at 14:30 China Standard Time. Location: 2F, No. 1688, Development Zone Avenue, Economic Development Zone, Rui'an, Zhejiang ChinaReported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.13 in 1Q 2023). Revenue: CN¥6.66b (up 7.5% from 1Q 2023). Net income: CN¥683.4m (up 8.2% from 1Q 2023). Profit margin: 10% (in line with 1Q 2023). Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.お知らせ • Mar 30Huafon Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024Valuation Update With 7 Day Price Move • Feb 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥6.99, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.68 per share.お知らせ • Dec 30Huafon Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.004 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.12 (up from CN¥0.004 in 3Q 2022). Revenue: CN¥7.06b (up 16% from 3Q 2022). Net income: CN¥569.9m (up CN¥548.7m from 3Q 2022). Profit margin: 8.1% (up from 0.3% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.21 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.21 in 2Q 2022). Revenue: CN¥6.43b (down 1.7% from 2Q 2022). Net income: CN¥727.2m (down 30% from 2Q 2022). Profit margin: 11% (down from 16% in 2Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.お知らせ • Jul 01Huafon Chemical Co., Ltd. to Report First Half, 2023 Results on Aug 11, 2023Huafon Chemical Co., Ltd. announced that they will report first half, 2023 results on Aug 11, 2023お知らせ • Jun 09Huafon Chemical Co., Ltd. Approves the Cash Dividend for the Year 2022Huafon Chemical Co., Ltd. approved the Cash dividend (tax included) of CNY 1.50000000 per 10 shares for the year 2022, at the AGM held on June 7, 2023.お知らせ • May 19Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2023 estimated continuing connected transactions; to consider confirmation of 2022 remuneration for directors, supervisors and senior management; and to consider other mattters.Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.29 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.29 in 1Q 2022). Revenue: CN¥6.19b (down 15% from 1Q 2022). Net income: CN¥631.4m (down 54% from 1Q 2022). Profit margin: 10% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Dec 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.0%. The fair value is estimated to be CN¥9.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 19% in 2 years. Earnings is forecast to grow by 23% in the next 2 years.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.004 (vs CN¥0.49 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.004 (down from CN¥0.49 in 3Q 2021). Revenue: CN¥6.10b (down 25% from 3Q 2021). Net income: CN¥21.2m (down 99% from 3Q 2021). Profit margin: 0.3% (down from 28% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.48 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.48 in 2Q 2021). Revenue: CN¥6.54b (down 7.8% from 2Q 2021). Net income: CN¥1.03b (down 53% from 2Q 2021). Profit margin: 16% (down from 31% in 2Q 2021). The decrease in margin was primarily driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Jun 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.5%. The fair value is estimated to be CN¥10.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 58%. Revenue is forecast to grow by 6.4% in 2 years. Earnings is forecast to grow by 0.5% in the next 2 years.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.35 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.29 (down from CN¥0.35 in 1Q 2021). Revenue: CN¥7.29b (up 26% from 1Q 2021). Net income: CN¥1.36b (down 17% from 1Q 2021). Profit margin: 19% (down from 28% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥8.12b (up 111% from 3Q 2020). Net income: CN¥2.28b (up 295% from 3Q 2020). Profit margin: 28% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year and the company’s share price has also increased by 46% per year.Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.085 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.10b (up 104% from 2Q 2020). Net income: CN¥2.21b (up 463% from 2Q 2020). Profit margin: 31% (up from 11% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Apr 13Full year 2020 earnings released: EPS CN¥0.49 (vs CN¥0.43 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥14.7b (up 6.4% from FY 2019). Net income: CN¥2.28b (up 24% from FY 2019). Profit margin: 16% (up from 13% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.06, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 134% over the past three years.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥13.66, the stock is trading at a trailing P/E ratio of 35.3x, down from the previous P/E ratio of 42.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 170%.Is New 90 Day High Low • Feb 20New 90-day high: CN¥16.20The company is up 56% from its price of CN¥10.41 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.24 per share.Is New 90 Day High Low • Jan 21New 90-day high: CN¥13.52The company is up 81% from its price of CN¥7.47 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.05 per share.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥12.26, the stock is trading at a trailing P/E ratio of 31.7x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 148%.Is New 90 Day High Low • Jan 06New 90-day high: CN¥11.51The company is up 56% from its price of CN¥7.40 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.07 per share.Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥9.85, the stock is trading at a trailing P/E ratio of 25.5x, up from the previous P/E ratio of 21.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 111%.Is New 90 Day High Low • Nov 09New 90-day high: CN¥8.99The company is up 25% from its price of CN¥7.20 on 11 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.57 per share.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.11b, down 17% from the prior year. Total revenue was CN¥15.8b over the last 12 months, down 19% from the prior year.業績と収益の成長予測XSEC:002064 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202829,3204,276N/A4,541212/31/202728,8063,785N/A5,002412/31/202628,6573,154N/A3,31813/31/202624,6512,0222,4854,100N/A12/31/202524,1981,8582,0233,740N/A9/30/202524,6681,6673,4754,974N/A6/30/202525,3241,6852,3633,636N/A3/31/202526,5882,0411,9573,189N/A12/31/202426,9312,2201,7313,025N/A9/30/202426,9892,5651,6943,010N/A6/30/202427,4202,6388492,031N/A3/31/202426,7642,5306172,327N/A12/31/202326,2982,4787522,469N/A9/30/202325,6252,357-1,558634N/A6/30/202324,6691,808-3802,224N/A3/31/202324,7832,1131002,442N/A1/1/202325,8842,844-372,570N/A9/30/202227,2934,2263,0895,424N/A6/30/202229,3106,4812,9555,823N/A3/31/202229,8667,6593,5986,029N/A1/1/202228,3677,9374,0206,135N/A9/30/202125,7977,1652,7525,214N/A6/30/202121,5205,4653,2424,836N/A3/31/202117,8933,6473,2995,060N/A12/31/202014,7242,2792,6284,209N/A9/30/202013,6031,7301,6763,191N/A6/30/202013,1511,6491,0002,857N/A3/31/202012,9361,784-1741,784N/A12/31/201913,7851,841N/A2,851N/A9/30/201921,8922,931N/A2,910N/A6/30/201919,6572,546N/A2,536N/A3/31/201917,6032,157N/A2,097N/A12/31/201815,1291,937N/A1,625N/A9/30/20184,477464N/A600N/A6/30/20184,509441N/A636N/A3/31/20184,172397N/A526N/A12/31/20174,150385N/A356N/A9/30/20173,921339N/A391N/A6/30/20173,466302N/A431N/A3/31/20173,242-229N/A547N/A12/31/20162,844-304N/A615N/A9/30/20162,615-361N/A966N/A6/30/20162,553-346N/A527N/A3/31/20162,609183N/A343N/A12/31/20152,547254N/A242N/A9/30/20152,505363N/A120N/A6/30/20152,394387N/A206N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 002064の予測収益成長率 (年間25% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 002064の収益 ( 25% ) CN市場 ( 27.1% ) よりも低い成長が予測されています。高成長収益: 002064の収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: 002064の収益 ( 6.5% ) CN市場 ( 16.3% ) よりも低い成長が予測されています。高い収益成長: 002064の収益 ( 6.5% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 002064の 自己資本利益率 は、3年後には低くなると予測されています ( 11.8 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/30 21:49終値2026/05/29 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Huafon Chemical Co.,Ltd 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Yilin HouChina International Capital Corporation LimitedDi WuChina International Capital Corporation LimitedXian Chao ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)8 その他のアナリストを表示
お知らせ • Apr 16Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China
お知らせ • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 22, 2026Huafon Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 22, 2026
お知らせ • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Mar 28, 2026Huafon Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Mar 28, 2026
お知らせ • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 25, 2025Huafon Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 25, 2025
お知らせ • Sep 04Huafon Chemical Co.,Ltd Proposes Interim Cash Dividend for the Year 2025Huafon Chemical Co.,Ltd proposed interim cash dividend of CNY 0.50000000 per 10 shares for the year 2025.
お知らせ • Jul 02Huafon Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 12, 2025Huafon Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 12, 2025
お知らせ • Apr 01Huafon Chemical Co.,Ltd Proposes Final Cash Dividend for the Year 2024Huafon Chemical Co.,Ltd announced that on 31 March 2025 the profit distribution proposal for 2024: Cash dividend (tax included) of CNY 1.50000000 per 10 shares.
お知らせ • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 26, 2025Huafon Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 26, 2025
お知らせ • Mar 29Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China
お知らせ • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Mar 29, 2025Huafon Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Mar 29, 2025
お知らせ • Oct 31Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd.Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd. on October 28, 2024. The consideration consist of cash and common equity.
お知らせ • Oct 30Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua.Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua on October 28, 2024. Huafon Chemical intends to acquire 100% of the equity of Zhejiang Huafon Synthetic Resin through issuing shares and paying cash. After the agreement is signed, both parties will continue to actively communicate, verify, and negotiate specific details of the transaction plan, transaction method, transaction price, share issuance price, share issuance quantity, and other matters, and will subsequently sign all formal agreements related to this transaction.
Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.12 in 3Q 2023). Revenue: CN¥6.63b (down 6.1% from 3Q 2023). Net income: CN¥496.5m (down 13% from 3Q 2023). Profit margin: 7.5% (down from 8.1% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 26, 2024Huafon Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥7.78, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.79 per share.
Reported Earnings • Aug 10Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥7.09b (up 10% from 2Q 2023). Net income: CN¥834.7m (up 15% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 29Huafon Chemical Co.,Ltd to Report First Half, 2024 Results on Aug 10, 2024Huafon Chemical Co.,Ltd announced that they will report first half, 2024 results on Aug 10, 2024
お知らせ • May 28Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024, at 14:30 China Standard Time. Location: 2F, No. 1688, Development Zone Avenue, Economic Development Zone, Rui'an, Zhejiang China
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.13 in 1Q 2023). Revenue: CN¥6.66b (up 7.5% from 1Q 2023). Net income: CN¥683.4m (up 8.2% from 1Q 2023). Profit margin: 10% (in line with 1Q 2023). Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 30Huafon Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024
Valuation Update With 7 Day Price Move • Feb 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥6.99, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.68 per share.
お知らせ • Dec 30Huafon Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.004 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.12 (up from CN¥0.004 in 3Q 2022). Revenue: CN¥7.06b (up 16% from 3Q 2022). Net income: CN¥569.9m (up CN¥548.7m from 3Q 2022). Profit margin: 8.1% (up from 0.3% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.21 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.21 in 2Q 2022). Revenue: CN¥6.43b (down 1.7% from 2Q 2022). Net income: CN¥727.2m (down 30% from 2Q 2022). Profit margin: 11% (down from 16% in 2Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.
お知らせ • Jul 01Huafon Chemical Co., Ltd. to Report First Half, 2023 Results on Aug 11, 2023Huafon Chemical Co., Ltd. announced that they will report first half, 2023 results on Aug 11, 2023
お知らせ • Jun 09Huafon Chemical Co., Ltd. Approves the Cash Dividend for the Year 2022Huafon Chemical Co., Ltd. approved the Cash dividend (tax included) of CNY 1.50000000 per 10 shares for the year 2022, at the AGM held on June 7, 2023.
お知らせ • May 19Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2023 estimated continuing connected transactions; to consider confirmation of 2022 remuneration for directors, supervisors and senior management; and to consider other mattters.
Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.29 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.29 in 1Q 2022). Revenue: CN¥6.19b (down 15% from 1Q 2022). Net income: CN¥631.4m (down 54% from 1Q 2022). Profit margin: 10% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Dec 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.0%. The fair value is estimated to be CN¥9.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 19% in 2 years. Earnings is forecast to grow by 23% in the next 2 years.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.004 (vs CN¥0.49 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.004 (down from CN¥0.49 in 3Q 2021). Revenue: CN¥6.10b (down 25% from 3Q 2021). Net income: CN¥21.2m (down 99% from 3Q 2021). Profit margin: 0.3% (down from 28% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.48 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.48 in 2Q 2021). Revenue: CN¥6.54b (down 7.8% from 2Q 2021). Net income: CN¥1.03b (down 53% from 2Q 2021). Profit margin: 16% (down from 31% in 2Q 2021). The decrease in margin was primarily driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Jun 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.5%. The fair value is estimated to be CN¥10.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 58%. Revenue is forecast to grow by 6.4% in 2 years. Earnings is forecast to grow by 0.5% in the next 2 years.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.35 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.29 (down from CN¥0.35 in 1Q 2021). Revenue: CN¥7.29b (up 26% from 1Q 2021). Net income: CN¥1.36b (down 17% from 1Q 2021). Profit margin: 19% (down from 28% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥8.12b (up 111% from 3Q 2020). Net income: CN¥2.28b (up 295% from 3Q 2020). Profit margin: 28% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year and the company’s share price has also increased by 46% per year.
Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.085 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.10b (up 104% from 2Q 2020). Net income: CN¥2.21b (up 463% from 2Q 2020). Profit margin: 31% (up from 11% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Apr 13Full year 2020 earnings released: EPS CN¥0.49 (vs CN¥0.43 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥14.7b (up 6.4% from FY 2019). Net income: CN¥2.28b (up 24% from FY 2019). Profit margin: 16% (up from 13% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.06, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 134% over the past three years.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥13.66, the stock is trading at a trailing P/E ratio of 35.3x, down from the previous P/E ratio of 42.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 170%.
Is New 90 Day High Low • Feb 20New 90-day high: CN¥16.20The company is up 56% from its price of CN¥10.41 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.24 per share.
Is New 90 Day High Low • Jan 21New 90-day high: CN¥13.52The company is up 81% from its price of CN¥7.47 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.05 per share.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥12.26, the stock is trading at a trailing P/E ratio of 31.7x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 148%.
Is New 90 Day High Low • Jan 06New 90-day high: CN¥11.51The company is up 56% from its price of CN¥7.40 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.07 per share.
Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥9.85, the stock is trading at a trailing P/E ratio of 25.5x, up from the previous P/E ratio of 21.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 111%.
Is New 90 Day High Low • Nov 09New 90-day high: CN¥8.99The company is up 25% from its price of CN¥7.20 on 11 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.57 per share.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.11b, down 17% from the prior year. Total revenue was CN¥15.8b over the last 12 months, down 19% from the prior year.